eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Roche Products Limited

Hexagon Place, 6 Falcon Way, Shire Park, Welwyn Garden City, Hertfordshire, AL7 1TW
Telephone: +44 (0)1707 366 000
Fax: +44 (0)1707 338 297
WWW: http://www.rocheuk.com
Medical Information Direct Line: +44 (0)800 328 1629
Medical Information e-mail: medinfo.uk@roche.com
Customer Care direct line: +44 (0)800 731 5711
Medical Information Fax: +44 (0)1707 384555

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Patient Information Leaflet last updated on the eMC: 10/08/2010
PIL Madopar Dispersible

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 10/08/2010 and displayed until Current
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 13/08/2009 and displayed until 10/08/2010
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 24/09/2007 and displayed until 13/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 24/08/2007 and displayed until 24/09/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/05/2006 and displayed until 24/08/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 08/03/2006 and displayed until 22/05/2006
Reasons for adding or updating:
  • Change to Marketing Authorisation Holder
  • Change to date of revision
Updated on 24/02/2003 and displayed until 08/03/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 16/11/2001 and displayed until 24/02/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 14/08/2000 and displayed until 16/11/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   levodopa
   benserazide hydrochloride